DUBLIN--(BUSINESS WIRE)--The "Global Cancer Vaccines Market - Segmented by Type, Technology, End User and Geography 2017 - 2022" report has been added to Research and Markets' offering.
The global cancer vaccines market to grow at a CAGR of 12-18% over the period (2017 - 2022). It is currently estimated to be valued at USD 2.1 billion for the year 2015.
The market for cancer vaccines is much smaller than other cancer therapeutic categories. The size of the market can be attributed to the nascent stages of industry life cycle and the late introduction of the vaccines in the market. To tap this market, many global companies are actively investing in cancer vaccine development. The market penetration is expected to increase with the increase in competition among the various pharmaceutical companies to obtain a larger portion of this market.
North America dominates the market, with the U.S. accounting for a major market share. However, Asia is poised to grow at the highest CAGR during the forecast period owing to the governmental initiatives, rising focus of major players on the Indian vaccine technology market, and increasing immunization initiatives by organizations such as World Health Organization and GAVI in these regions.
The Global Cancer Vaccines Market is segmented based on:
- Technology
- Subunit Vaccines
- Live Attenuated Vaccines
- Conjugate Vaccines
- Inactivated Vaccines
- Recombinant Vector Vaccines
- Toxoid Vaccines
- Synthetic Vaccines
- Dendritic Cell Vaccines
Type
- Preventive Vaccines
- Therapeutic Vaccines
- Disease Indication
- Cervical cancer
-
Others
Drivers:
- Increasing cancer cases
- Technological developments
- Drug innovations with regard to the cancer
- Government initiatives
- Rise in aging populace
- Advanced health care services
- Upsurge in awareness about cancer and their available therapies in the market
- Increasing health care expenditure
Restraints:
- Cold chain, or temperature-controlled supply chain, management
- Low accessibility to vaccines in remote areas
- Stringent regulatory procedures
Key Topics Covered:
1. Executive Summary
2. Research Methodology
3. Introduction
4. Market Overview
5. Porters Five Force Analysis
6. Market Segmentation
7. Competitive Landscape
8. Company Profiles
- AstraZeneca plc
- Aduro BioTech
- Cytos
- Galena Biopharma
- Juvaris Biotherapeutics
- MedImmune
- Oxford BioMedica
- Prima BioMed
- GlaxoSmithKline
- Sanofi
- Merk&co
- Ubivac
- Vaccinogen
For more information about this report visit https://www.researchandmarkets.com/research/9lzlwv/global_cancer
